147 related articles for article (PubMed ID: 9027613)
1. Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization.
Giner Moreno E; Quereda-Flores F; Hernández Chinchilla JA; Amigo Moreno R; Perez Ruiz MD; Carcelén López A; Rocher Benlloch J; Molió Sanchís P; Casares Calzada A; Marqués-Torrejón MÁ; Martínez-Cadenas C; Ruiz Cerdá JL; Loras Monfort A; Ramos Soler D
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38047572
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and prostate cancer: MicroRNAs comes into view.
Gupta J; Tayyib NA; Jalil AT; Hlail SH; Zabibah RS; Vokhidov UN; Alsaikhan F; Ramaiah P; Chinnasamy L; Kadhim MM
Pathol Res Pract; 2023 Aug; 248():154591. PubMed ID: 37343381
[TBL] [Abstract][Full Text] [Related]
3. Implication of cell kinetic changes during the progression of human prostatic cancer.
Berges RR; Vukanovic J; Epstein JI; CarMichel M; Cisek L; Johnson DE; Veltri RW; Walsh PC; Isaacs JT
Clin Cancer Res; 1995 May; 1(5):473-80. PubMed ID: 9816006
[TBL] [Abstract][Full Text] [Related]
4. Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.
Klein EA
Rev Urol; 2002; 4 Suppl 5(Suppl 5):S18-28. PubMed ID: 16986062
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
Singh RP; Raina K; Sharma G; Agarwal R
Clin Cancer Res; 2008 Dec; 14(23):7773-80. PubMed ID: 19047104
[TBL] [Abstract][Full Text] [Related]
6. Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.
Demark-Wahnefried W; George SL; Switzer BR; Snyder DC; Madden JF; Polascik TJ; Ruffin MT; Vollmer RT
Clin Trials; 2008; 5(3):262-72. PubMed ID: 18559416
[TBL] [Abstract][Full Text] [Related]
7. Assays for complexed prostate-specific antigen and other advances in the diagnosis of prostate cancer.
Brawer MK
Rev Urol; 2003; 5 Suppl 6(Suppl 6):S10-6. PubMed ID: 16985971
[TBL] [Abstract][Full Text] [Related]
8. Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk.
El Sheikh SS; Domin J; Abel P; Stamp G; Lalani el-N
Neoplasia; 2003; 5(2):99-109. PubMed ID: 12659682
[TBL] [Abstract][Full Text] [Related]
9. Prostatic intraepithelial neoplasia is a risk factor for cancer.
Bostwick DG
Semin Urol Oncol; 1999 Nov; 17(4):187-98. PubMed ID: 10632120
[TBL] [Abstract][Full Text] [Related]
10. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
Bostwick DG; Aquilina JW
J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
[TBL] [Abstract][Full Text] [Related]
11. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials.
Bostwick DG; Burke HB; Wheeler TM; Chung LW; Bookstein R; Pretlow TG; Nagle RB; Montironi R; Lieber MM; Veltri RW
J Cell Biochem Suppl; 1994; 19():283-9. PubMed ID: 7529857
[TBL] [Abstract][Full Text] [Related]
12. Intermediate biomarkers for chemoprevention of prostate cancer.
van der Kwast TH
IARC Sci Publ; 2001; 154():199-205. PubMed ID: 11220659
[TBL] [Abstract][Full Text] [Related]
13. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
Crawford ED; DeAntoni EP; Ross CA
J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
[TBL] [Abstract][Full Text] [Related]
14. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
